Oral Taigexyn nemonoxacin regulatory update

TaiGen said the Taiwan Food and Drug Administration (TFDA) approved an NDA for oral Taigexyn nemonoxacin to treat communityacquired bacterial pneumonia (CABP). The non-fluorinated quinolone antibiotic...